A detailed history of Mayflower Financial Advisors, LLC transactions in Danaher Corp stock. As of the latest transaction made, Mayflower Financial Advisors, LLC holds 2,534 shares of DHR stock, worth $510,905. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,534
Previous 2,457 3.13%
Holding current value
$510,905
Previous $683,000 14.93%
% of portfolio
0.09%
Previous 0.11%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 22, 2025

BUY
$226.16 - $274.52 $17,414 - $21,138
77 Added 3.13%
2,534 $581,000
Q3 2024

Nov 04, 2024

SELL
$239.25 - $280.76 $18,422 - $21,618
-77 Reduced 3.04%
2,457 $683,000
Q2 2024

Aug 02, 2024

BUY
$235.51 - $267.98 $10,126 - $11,523
43 Added 1.73%
2,534 $633,000
Q1 2024

Apr 29, 2024

BUY
$224.58 - $256.19 $113,188 - $129,119
504 Added 25.36%
2,491 $622,000
Q4 2023

Jan 22, 2024

BUY
$185.1 - $233.13 $86,997 - $109,571
470 Added 30.98%
1,987 $459,000
Q3 2023

Oct 12, 2023

BUY
$233.08 - $265.59 $38,458 - $43,822
165 Added 12.2%
1,517 $376,000
Q2 2023

Jul 13, 2023

BUY
$224.99 - $256.14 $55,797 - $63,522
248 Added 22.46%
1,352 $324,000
Q1 2023

Apr 12, 2023

BUY
$239.75 - $277.0 $7,192 - $8,310
30 Added 2.79%
1,104 $278,000
Q4 2022

Jan 25, 2023

BUY
$241.42 - $282.29 $259,285 - $303,179
1,074 New
1,074 $0
Q3 2022

Oct 19, 2022

SELL
$247.06 - $1507.4 $254,224 - $1.55 Million
-1,029 Reduced 49.23%
1,061 $274,000
Q3 2022

Oct 17, 2022

BUY
$247.06 - $1507.4 $516,355 - $3.15 Million
2,090 New
2,090 $540,000
Q1 2022

Apr 21, 2022

SELL
$257.27 - $315.76 $166,453 - $204,296
-647 Closed
0 $0
Q4 2021

Jan 21, 2022

SELL
$292.08 - $329.01 $19,569 - $22,043
-67 Reduced 9.38%
647 $213,000
Q3 2021

Oct 26, 2021

BUY
$272.21 - $332.43 $194,357 - $237,355
714 New
714 $220,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $147B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Mayflower Financial Advisors, LLC Portfolio

Follow Mayflower Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mayflower Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mayflower Financial Advisors, LLC with notifications on news.